deaths related to semaglutide The letter cited three among patients using semaglutide, the active ingredient in several of its weight-loss medications, which it said were not properly investigated or reported. Read more at the link Research shows semaglutide — commonly

Granted/Publication/Reissued Date Granted Date: The date a patent is granted and ceases being a patent application

Improved understanding of the contributors to the observed decrease in dementia incidence, quantifying the role of changes in cardiovascular risk profiles and educational attainment for example, may open opportunities to accelerate prevention efforts and to better use public health investments not specifically targeted to AD/ADRD (e.g., initiatives aimed at improving cardiovascular health)

Recently, a combined research group from Sweden and the United States demonstrated for the first time the presence of activated glia, resulting in active neuro-inflammation in the brains of fibromyalgia patients

doi: 10.2337/dc22-S009 8 Gerhart-HinesZLazarMA